BioPharma Credit PLC (FRA:B3P)
Germany · Delayed Price · Currency is EUR 0.7650
+0.0100 (1.32%)
At close: Jan 29, 2026
BioPharma Credit Market Cap
BioPharma Credit has a market cap or net worth of €878.24 million as of January 30, 2026. Its market cap has decreased by -9.29% in one year.
Market Cap
878.24M
Enterprise Value
874.61M
Revenue
131.70M
Ranking
n/a
PE Ratio
8.38
Stock Price
€0.77
Market Cap Chart
Since March 27, 2017, BioPharma Credit's market cap has increased from 499.76M to 878.24M, an increase of 75.73%. That is a compound annual growth rate of 6.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 878.24M | -0.31% |
| Dec 31, 2025 | 880.98M | -13.09% |
| Dec 31, 2024 | 1.01B | 2.39% |
| Dec 29, 2023 | 989.97M | -15.58% |
| Dec 30, 2022 | 1.17B | 0.28% |
| Dec 31, 2021 | 1.17B | 4.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gelsenwasser AG | 1.82B |
| tonies SE | 1.14B |
| Sedlmayr Grund und Immobilien AG | 939.90M |
| Berliner Effektengesellschaft AG | 879.96M |
| Maschinenfabrik Berthold Hermle AG | 835.00M |
| Northern Data AG | 815.30M |
| Paul Hartmann AG | 774.28M |
| EUROKAI GmbH & Co. KGaA | 697.65M |